Diabetes Drug Shows Slight Effect on Dementia in German Study

in 2014, Benjamin Wolozin, Bloomberg, Centers & Institutes in the News, Newsmakers, School of Medicine
July 14th, 2014

Benjamin Wolozin, School of Medicine, Alzheimer’s Disease Center

Older Germans who took Takeda Pharmaceutical Co. (4502)’s diabetes medicine Actos were slightly less likely to develop dementia, according to a study that may do little to resolve questions about the drug’s usefulness…

Expert quote:

“It was very important to do this study. However, it’s actually almost surprising to me that the lowering of relative risk was so weak.”

View full article

Comments are closed.